An open labelled randomized controlled clinical study to evaluate the anti-hyperglycemic activity of novel ayurvedic choorna in the management of prameha vis-a-vis type2 diabetes mellitus - nil

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital Hassan Karnataka0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Subjects of all gender and age group between 30-60 years will be included.
•Subjects with FBS greater than or equal to 126mg/dl and or PPBS greater than or equal to 200mg/dl will be included.
•Subjects with HbA1c greater than or equal to 6.5%
•Diagnosed cases of Type2 Diabetes Mellitus.
•Subjects with and without signs and symptoms of Prameha vis-a-vis Type2 Diabetes Mellitus will be included.

•Subjects with history of Diabetes Mellitus associated with complications like diabetic nephropathy, retinopathy, neuropathy, infectious wounds and gangrene will be excluded.
•Patients with known systemic disorders like; cardiac illness, renal pathologies, other endocrinal diseases, uncontrolled hypertension, infectious conditions and debilitating illness which interfere with intervention will be excluded.
•Patients of Type 2 Diabetes Mellitus who are on OHA and Insulin treatment will be excluded.
•Subjects on any other medications, drug and alcohol abuse, Steroids and Estrogen replacement therapy will be excluded.
•Pregnant and the lactating women will be excluded.

发起方

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital Hassan Karnataka